| scholarly article | Q13442814 |
| P953 | full work available at URL | http://molpharm.aspetjournals.org/cgi/content/abstract/25/3/436 |
| P698 | PubMed publication ID | 6203026 |
| P2093 | author name string | M. Rossi | |
| R. L. Momparler | |||
| C. Vaccaro | |||
| J. Bouchard | |||
| L. F. Momparler | |||
| S. Bartolucci | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytosine nucleotides | Q73857340 |
| P304 | page(s) | 436-440 | |
| P577 | publication date | 1984-05-01 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase | |
| P478 | volume | 25 |
| Q26743743 | A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers |
| Q27323225 | CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil |
| Q27011914 | DNA demethylation and invasive cancer: implications for therapeutics |
| Q36284232 | Decitabine: a historical review of the development of an epigenetic drug |
| Q67535912 | Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase |
| Q33878949 | SAMHD1 protects cancer cells from various nucleoside-based antimetabolites |
| Q38119782 | The promise and failures of epigenetic therapies for cancer treatment |
| Q37765469 | Therapy with azanucleosides for myelodysplastic syndromes |
Search more.